Atherosclerosis

Papers
(The H4-Index of Atherosclerosis is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES148
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON125
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY106
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES106
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON105
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling94
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial94
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation88
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis84
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis76
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue76
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia76
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease73
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence73
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT73
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity72
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease70
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol65
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement65
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus64
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis63
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis60
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow56
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n54
ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY52
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS52
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL51
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN51
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]50
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study49
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention46
Rabies vaccine induced microangiopathy46
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain44
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage43
Vascular structural changes in diabetes mellitus patients with chronic kidney disease43
Illness perception in patients with familial hypercholesterolemia42
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality41
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”38
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue38
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification38
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial38
0.095824003219604